Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Signal Twitter WhatsApp YouTube

Ryann Grochowski Jones

Deputy Editor, Data

Photo of Ryann Grochowski Jones

Ryann Grochowski Jones is the deputy data editor at ProPublica. Previously, she was a data reporter at ProPublica and at Investigative Newsource/KPBS in San Diego, California. She received her master’s degree from the University of Missouri School of Journalism, where she was a data librarian for Investigative Reporters and Editors/National Institute for Computer-Assisted Reporting. Ryann started her career as a municipal beat reporter for her hometown newspaper in Wilkes-Barre, Pennsylvania.

The Road to Health is Paved With Good Data

The nonprofit Health Data Consortium held its fifth-annual Health Datapalooza last week in Washington, D.C. Here are some highlights.

How We Analyzed Medicare Part B Data

Using recently released Medicare data, we examined how doctors and other health professionals billed for office visits, one of the most common services patients receive. We found some doctors who billed for the most costly, most complex visits almost exclusively and charged top rates far more than their peers.

Treatment Tracker

Medicare recently released, for the first time, details on 2012 payments to individual doctors and other health professionals serving the 46 million seniors and disabled in its Part B program. Part B covers services as varied as office visits, ambulance mileage, lab tests, and the doctor’s fee for open-heart surgery. Use this tool to find and compare providers.

Top Billing: Meet the Docs who Charge Medicare Top Dollar for Office Visits

Medicare paid for more than 200 million office visits for established patients in 2012. Overall, health professionals classified only 4 percent as complex enough to command the most expensive rates. But 1,800 providers billed at the top level at least 90 percent of the time, a ProPublica analysis found. Experts question whether the charges are legitimate.

Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their Research

Research has been seen as less objectionable than other forms of interactions with drug companies, but 10 percent of researchers have multiple ties among the nine companies ProPublica analyzed. That raises questions about doctors’ impartiality.

As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets

As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks. This fall, all drug and medical device companies will be required to report payments to doctors.

Introducing the ProPublica Data Store

How We Analyzed Medicare’s Drug Data

ProPublica obtained Medicare Part D data from the Centers for Medicare and Medicaid Services (CMS) under the Freedom of Information Act. Here follows more information about the data and how we analyzed it.

Dollars for Docs: See What Payments Your Doctor May Be Getting From Drug Companies

Has Your Doctor Received Drug Company Money?

Follow ProPublica

Latest Stories from ProPublica

Current site Current page